Circulating Extracellular Vesicles: An Effective Biomarker for Cancer Progression

被引:1
|
作者
Chatterjee, Madhura [1 ]
Gupta, Saurabh [2 ]
Nag, Sayoni [3 ]
Rehman, Ishita [4 ]
Parashar, Deepak [5 ]
Maitra, Arindam [1 ]
Das, Kaushik [1 ]
机构
[1] Natl Inst Biomed Genom, Biotechnol Res & Innovat Council, Kalyani 741251, India
[2] GLA Univ, Dept Biotechnol, Mathura 281406, India
[3] Brainware Univ, Dept Biotechnol, Barasat 700125, India
[4] Neotia Univ, Dept Biotechnol, Parganas 743368, India
[5] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2024年 / 29卷 / 11期
关键词
biomarkers; cancer biomarkers; circulating extracellular vesicles; clinical trials; extracellular vesicles; therapeutics; POTENTIAL DIAGNOSTIC BIOMARKERS; EXOSOME-MEDIATED TRANSFER; INTERCELLULAR COMMUNICATION; CELLS PROMOTES; MESSENGER-RNA; PROGNOSTIC BIOMARKER; SERUM EXOSOMES; MICROVESICLES; EXPRESSION; MECHANISM;
D O I
10.31083/j.fbl2911375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs), the ubiquitous part of human biology, represent a small heterogenous, membrane-enclosed body that contains a diverse payload including genetic materials in the form of DNA, RNAs, small non-coding RNAs, etc. mostly mirroring their source of origin. Since, a vast majority of research has been conducted on how nucleic acids, proteins, lipids, and metabolites, associated with EVs can be effectively utilized to identify disease progression and therapeutic responses in cancer patients, EVs are increasingly being touted as valuable and reliable identifiers of cancer biomarkers in liquid biopsies. However, the lack of comprehensive clinical validation and effective standardization protocols severely limits its applications beyond the laboratories. The present review focuses on understanding the role of circulating EVs in different cancers and how they could potentially be treated as cancer biomarkers, typically due to the presence of bioactive molecules such as small non-coding RNAs, RNAs, DNA, proteins, etc., and their utilization for fine-tuning therapies. Here, we provide a brief general biology of EVs including their classification and subsequently discuss the source of circulatory EVs, the role of their associated payload as biomarkers, and how different cancers affect the level of circulatory EVs population.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension
    Abolbaghaei, Akram
    Turner, Maddison
    Thibodeau, Jean-Francois
    Holterman, Chet E. E.
    Kennedy, Christopher R. J.
    Burger, Dylan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [32] Role of tumor-derived extracellular vesicles in cancer progression and their clinical applications (Review)
    Qiao, Fuhao
    Pan, Peng
    Yan, Jiaping
    Sun, Jing
    Zong, Yan
    Wu, Zhiyong
    Lu, Xiaoqin
    Chen, Na
    Mi, Rui
    Ma, Yongbin
    Ji, Yuan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (05) : 1525 - 1533
  • [33] Lectins as potential tools for cancer biomarker discovery from extracellular vesicles
    Islam, Md. Khirul
    Khan, Misba
    Gidwani, Kamlesh
    Witwer, Kenneth W.
    Lamminmaeki, Urpo
    Leivo, Janne
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [34] CIRCULATING EXTRACELLULAR VESICLES AS A POTENTIAL BIOMARKER OF INTERSTITIAL LUNG DISEASE AND ITS PROGRESSION IN SYSTEMIC SCLEROSIS -A PROSPECTIVE COHORT STUDY
    Colic, J.
    Pruner, I.
    Damjanov, N.
    Antovic, J.
    Bukilica, M. Sefik
    Antovic, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 985 - 986
  • [35] The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping
    Platko, Khrystyna
    Haas-Neill, Sandor
    Aziz, Tariq
    Al-Nedawi, Khalid
    BREAST JOURNAL, 2019, 25 (04) : 691 - 695
  • [36] Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
    Moon, Pyong-Gon
    Lee, Jeong-Eun
    Cho, Young-Eun
    Lee, Soo Jung
    Chae, Yee Soo
    Jung, Jin Hyang
    Kim, In-San
    Park, Ho Yong
    Baek, Moon-Chang
    ONCOTARGET, 2016, 7 (26) : 40189 - 40199
  • [37] Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
    Brocco, D.
    Lanuti, P.
    Simeone, P.
    Bologna, G.
    Pieragostino, D.
    Cufaro, M. C.
    Graziano, V.
    Peri, M.
    Di Marino, P.
    De Tursi, M.
    Grassadonia, A.
    Rapposelli, I. G.
    Pierdomenico, L.
    Ercolino, E.
    Ciccocioppo, F.
    Del Boccio, P.
    Marchisio, M.
    Natoli, C.
    Miscia, S.
    Tinari, N.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [38] Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy
    Di Santo, Riccardo
    Vaccaro, Maria
    Romano, Sabrina
    Di Giacinto, Flavio
    Papi, Massimiliano
    Rapaccini, Gian Ludovico
    De Spirito, Marco
    Miele, Luca
    Basile, Umberto
    Ciasca, Gabriele
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [39] Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy
    Koenig, Lisa
    Kasimir-Bauer, Sabine
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Wagner, Bettina
    Santos Manvailer, Luis Felipe
    Kimmig, Rainer
    Horn, Peter A.
    Rebmann, Vera
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [40] The role of the metabolite cargo of extracellular vesicles in tumor progression
    Harmati, Maria
    Bukva, Matyas
    Boroczky, Timea
    Buzas, Krisztina
    Gyukity-Sebestyen, Edina
    CANCER AND METASTASIS REVIEWS, 2021, 40 (04) : 1203 - 1221